Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
197 Leser
Artikel bewerten:
(0)

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Axiom Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / July 3, 2017 / Khang & Khang LLP (the "Firm") announces the filing of a securities class action lawsuit against Axiom Holdings, Inc. ("Axiom" or the "Company") (OTC PINK: AIOM). Investors who purchased or otherwise acquired shares between October 14, 2016 and June 19, 2017, inclusive (the "Class Period"), are encouraged to contact the Firm before the August 21, 2017 lead plaintiff motion deadline.

If you purchased Axiom shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Axiom made false and misleading statements and/or failed to disclose that: the Company lacked control over the merger process sufficient to ensure that its share exchange agreement with CJC Holdings, Ltd. ("CJC") would be completed; that the agreement with CJC was never completed; that Axiom Holdings' issuance of shares to the CJC Shareholders was thus improper; and that as a result of the above, the Company's public statements were materially false and misleading at all relevant times. On June 19, 2017, Axiom disclosed that it identified discrepancies related to prior news announcements in response to a subpoena from the U.S. Securities and Exchange Commission. The following day, the Company issued another press release, advising investors that "it now appears the merger was never completed" and advising investors that it would rescind the shares that were issued to the CJC Shareholders in connection with the merger. When this news was announced, shares of Axiom lowered in value materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2017 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.